Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01556919 · ClinicalTrials.gov registry record
Esophageal Monitoring Device for Assessing Mucosal Impedance
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 429
- Enrollment target
NCT01556919 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 429 participants.
The verdict
NCT01556919 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 429 participants
- Enrollment target
Study Summary
The investigators are looking at a novel approach to measuring gastroesophageal reflux disease (GERD) damage and reducing the need for costly and less optimal testing presently used for diagnostic and treatment purposes. The investigators will be using three custom mucosal impedance (MI) catheters, each designed to measure at slightly different spacing on the esophagus.
Interventions
- PROCEDURE Standard of care endoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 429 participants |
| Start Date | 2012-03 |
| Est. Completion | 2021-07-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01556919
The ClinicalTrials.gov registry entry for NCT01556919 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 429 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Standard of care endoscopy is the first listed.
NCT01556919 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01556919 about?
NCT01556919 is a clinical study titled "Esophageal Monitoring Device for Assessing Mucosal Impedance". The investigators are looking at a novel approach to measuring gastroesophageal reflux disease (GERD) damage and reducing the need for costly and less optimal testing presently used for diagnostic and treatment purposes. The investigators will be using three custom mucosal impedance (MI) catheters, ...
What is the current status of trial NCT01556919?
This trial is currently completed. The enrollment target is 429 participants. The study started on 2012-03. Estimated completion is 2021-07-23.
What interventions are being tested in trial NCT01556919?
The interventions under investigation include: Standard of care endoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT01556919?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.